Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-02-21

Clinical Trial Update: TXA Soaked Gelatin Sponge to Reduce Rectus Sheath Hematoma After C.S. in Patients Using Warfarin [Phase 4]

View source ↗

Summary

Phase 4 trial assessing TXA-soaked gelatin sponge to reduce rectus sheath hematoma after cesarean section in patients on warfarin; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TXA-soaked gelatin sponge (tranexamic acid soaked gelatin sponge)

Snippet

Sponsor: Cairo University | Conditions: Rectus Sheath Hematoma, Cesarean Section | Phase 4 | Status: COMPLETED